Prestige Biopharma group to showcase at CPhI Frankfurt 2022 on Nov 1-3

 

Prestige Biopharma group booth at CPhI 2021 (Photo: Business Wire) 

KUALA LUMPUR, Oct 27 (Bernama) -- Prestige Biopharma group, comprised of Prestige Biopharma Limited and Prestige Biologics Co Ltd, announced that it will be appearing at CPhI Frankfurt 2022 on Nov 1-3, at Messe Frankfurt, Germany.

The Prestige group will showcase its latest antibody drug pipeline and innovative CDMO service at a large-scale independent booth, according to a statement.

At the booth, clients and visitors are invited to take part in the experience zones and a transparent OLED display will be exhibited to highlight the EU-GMP certified facility and 154,000 liters of global-scale production capacity of Prestige Biologics in South Korea.

“We are excited to provide an inside look into Prestige Biopharma group at CPhI 2022 and are looking forward to having meaningful partner discussions.

“We will be introducing our capabilities for development and manufacturing of antibody and vaccine therapeutics, to support our partners to bring life-saving medicines to the patient,” said head of global business development of Prestige Biopharma, Dr Michael Ruppert.

The Prestige group looks forward to the on-site collaboration with biopharmaceutical partners at CPhI Frankfurt 2022.

Prestige Biopharma group will continue to pursue ‘innovation for life’ in every area which is the group’s business purpose, while ensuring corporate DNA, innovation, efficiency and agility, to ultimately create a difference for humanity.

More details at www.prestigebio.com.

-- BERNAMA